Syndax Pharmaceuticals Stock Options Expiring on 21st of February

SNDX Stock  USD 14.10  0.98  7.47%   

Syndax Pharmaceuticals Corporate Management

Briggs MDHead PresProfile
Steven ClosterChief OfficerProfile
Michael MBACEO DirectorProfile
Steve SabusChief OfficerProfile
Joseph MDMember OfficerProfile
Ronald EvansAdvisor CoFounderProfile
Sharon KlahreVice CommunicationsProfile

Additional Tools for Syndax Stock Analysis

When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.